Evidence map›Paper›PMID 39788779›Full record

ArticleBMJ open2025

Powerful together with diabetes, a group-based self-management intervention for patients with type 2 diabetes from lower educational groups: study protocol for a hybrid type 2 evaluation.

Bedra Horreh, Femke van Nassau, Lorraine Landais, Charlotte Vissenberg, Johanna M van Dongen, Hidde P van der Ploeg, Karien Stronks

Abstract readClinical Trial Protocol
In one paragraph

Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Bedra HorrehPublic and Occupational health, Amsterdam UMC Locatie VUmc Divisie 10, Amsterdam, Noord Holland, The Netherlands b.horreh@amsterdamumc.nl.ORCID http://orcid.org/0000-0002-7659-1180
Femke van NassauVrije Universiteit Amsterdam, Department of Public and Occupational health, Amsterdam Public Health Institute, Amsterdam University Medical Centres, Amsterdam, Noord-Holland, The Netherlands.
Lorraine LandaisAmsterdam UMC Locatie VUmc, Amsterdam, Noord-Holland, The Netherlands.
Charlotte VissenbergWindesheim Flevoland, Almere, Flevoland, The Netherlands.
Johanna M van DongenVrije Universiteit Amsterdam, Amsterdam, The Netherlands.
Hidde P van der PloegVrije Universiteit Amsterdam, Department of Public and Occupational health, Amsterdam Public Health Institute, Amsterdam University Medical Centres, Amsterdam, Noord-Holland, The Netherlands.
Karien StronksAmsterdam University Medical Centres, Amsterdam, Noord-Holland, The Netherlands.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionType 2 diabetes mellitus (T2DM) is a major burden on public health worldwide. To reduce adverse events and complications, effective T2DM self-management is required. Self-management and glycaemic control are generally poorer in lower educated people compared with higher educated people. This study aims to assess the (cost-)effectiveness and to conduct a process evaluation of a diabetes self-management programme, 'Powerful Together With Diabetes' (PTWD), which is specifically developed for patients from lower educational groups. METHODS AND ANALYSIS: The PTWD programme is focused on attaining basic knowledge and skills for effective diabetes self-management. In a previous study (the Diabetes in Social Context (DISC) study), lower-educated participants enjoyed the PTWD programme as well as improved their T2DM-related behaviours. The design of the study is an effectiveness-implementation hybrid type 2 trial. We will conduct mixed methods effectiveness, process and economic evaluations. To investigate the (cost-)effectiveness, a two-arm quasi-experimental trial will be conducted with a parallel mixed method process evaluation. The primary outcome of the study is change in haemoglobin A1c levels from baseline to 12 months. Secondary outcomes include use of primary and secondary care, medication use, blood biomarkers, T2DM self-management health behaviours, anthropometrics, and quality of life. Data will be collected with questionnaires, physical activity trackers and registration data from general practitioner registries. To see if the results are maintained, we will also measure the outcomes 24 months after baseline. Study participants are patients from lower educational groups living with T2DM between 35 and 70 years old. Participants will be recruited through general practices, and the intervention will be held in community centres. Our aim is to include 114 participants in the intervention group and 570 participants in the control group. ETHICS AND DISSEMINATION: This study has been approved by the Medical Ethics Committee of the Academic Medical Center in Amsterdam (#2021_222). Participants will sign an informed consent form prior to enrolment. Manuscripts with the results of the effectiveness, economic and process evaluations will be published in peer-reviewed journals. TRIAL REGISTRATION NUMBER: ISRCTN12982302 ISRCTN registry (registered on 29 March 2022).

Indexed as

Diabetes Mellitus, Type 2Educational StatusSelf-ManagementAdultAgedCost-Benefit AnalysisGlycated HemoglobinHumansMaleMiddle AgedPatient Education as TopicQuality of LifeGlycated HemoglobinDiabetes & endocrinologyHealth LiteracyPrimary Health CarePUBLIC HEALTHQuality of LifeSelf-Management

Identifiers

PMID39788779
PMCPMC11751900

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.